NCT01792713View on ClinicalTrials.gov

Sertaconazole 2% Cream to Improve Symptoms Associated With Atopic Dermatitis

PHASE2CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

September 30, 2013

Study Completion Date

February 28, 2014

Conditions
Skin Alterations Associated With Atopic Dermatitis
Interventions
DRUG

Sertaconazole 2% cream

DRUG

Placebo

Trial Locations (2)

10117

Universitätsmedizin Charité Berlin, Abteilung für Dermatologie und Allergologie, Berlin

48149

Universitätsklinikum Münster, Klinik für Hautkrankheiten, Münster

All Listed Sponsors
lead

Spirig Pharma Ltd.

INDUSTRY

NCT01792713 - Sertaconazole 2% Cream to Improve Symptoms Associated With Atopic Dermatitis | Biotech Hunter | Biotech Hunter